AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 64 filers reported holding AVROBIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,083 | -4.2% | 83,820 | -40.9% | 0.00% | – |
| Q2 2023 | $134,685 | -35.2% | 141,759 | -31.8% | 0.00% | – |
| Q1 2023 | $208,000 | +1223429.4% | 207,979 | +781.3% | 0.00% | – |
| Q4 2022 | $17 | -100.0% | 23,598 | -65.6% | 0.00% | – |
| Q3 2022 | $44,000 | -97.7% | 68,666 | -96.8% | 0.00% | – |
| Q2 2022 | $1,950,000 | -25.9% | 2,120,044 | +6.3% | 0.00% | – |
| Q1 2022 | $2,632,000 | -84.9% | 1,994,391 | -56.0% | 0.00% | -100.0% |
| Q4 2021 | $17,465,000 | -32.1% | 4,536,431 | -1.6% | 0.00% | -33.3% |
| Q3 2021 | $25,722,000 | -40.8% | 4,609,602 | -5.7% | 0.00% | -40.0% |
| Q2 2021 | $43,457,000 | -30.6% | 4,888,316 | -0.9% | 0.01% | -37.5% |
| Q1 2021 | $62,583,000 | -0.4% | 4,931,655 | +9.5% | 0.01% | -11.1% |
| Q4 2020 | $62,810,000 | +29.6% | 4,505,745 | +24.0% | 0.01% | +12.5% |
| Q3 2020 | $48,455,000 | -7.0% | 3,634,982 | +21.7% | 0.01% | -20.0% |
| Q2 2020 | $52,128,000 | +29.3% | 2,987,283 | +15.3% | 0.01% | +11.1% |
| Q1 2020 | $40,323,000 | -6.6% | 2,591,492 | +20.8% | 0.01% | +12.5% |
| Q4 2019 | $43,191,000 | +55.5% | 2,145,590 | +9.1% | 0.01% | +33.3% |
| Q3 2019 | $27,778,000 | +24.9% | 1,967,288 | +35.9% | 0.01% | +50.0% |
| Q2 2019 | $22,244,000 | -17.6% | 1,448,130 | +18.3% | 0.00% | -33.3% |
| Q1 2019 | $26,999,000 | +152.7% | 1,224,455 | +90.8% | 0.01% | +200.0% |
| Q4 2018 | $10,686,000 | -61.7% | 641,816 | +19.4% | 0.00% | -60.0% |
| Q3 2018 | $27,871,000 | +199.8% | 537,322 | +65.1% | 0.01% | +150.0% |
| Q2 2018 | $9,296,000 | – | 325,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |